Angiotensin-converting–enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs) are recommended widely as first-line treatments for hypertension in patients with diabetic or nondiabetic ...

In a patient on an ACE inhibitor, how do you monitor serum creatinine, especially when it’s starting to rise? Do you ever stop the ACE inhibitor and change to another BP medication? How does the ...

ACE inhibitors are well-established for limiting morbidity and mortality after MI, particularly in patients with LV dysfunction, heart failure, or both. To test the hypothesis that an ...

Since the introduction of ARBs, the question that has pervaded each clinician’s mind is whether or not these drugs serve an advantage in conditions long addressed by ACE inhibitors. Matchar et al ...

ACE inhibitors may reduce all-cause mortality in IPF patients, suggesting potential repurposing for this progressive disease. The study used electronic health records from 3579 IPF patients, matched ...

Please provide your email address to receive an email when new articles are posted on . There was a significant independent link between angiotensin-converting enzyme inhibitor use and all-cause ...